Kai-Uwe Eckardt

3.1k citations
4 papers · 2.3k indexed · 2 hit papers · h-index 4
  • Nephrology top 0.5%
  • Hematology top 0.5%
    • Erythropoietin and Anemia Treatment 3
    • Iron Metabolism and Disorders 1
  • Genetics top 2%
    • Hemoglobinopathies and Related Disorders 1
    • Mesenchymal stem cell research 1
    • High Altitude and Hypoxia 1
    • Cancer, Hypoxia, and Metabolism 1
    • Blood transfusion and management 1
    • Erythrocyte Function and Pathophysiology 1

Kai-Uwe Eckardt

4 papers receiving 2.3k citations

Hit Papers

A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chroni...1.4k20072026201320194008001.2k

Peers

Kai-Uwe Eckardt
Comparison fields: 5 of 100
  • Nephrology 921
  • Hematology 1.1k
  • Genetics 456
  • Cancer Research 381
  • Biochemistry 128
Replace Reshma Kewalramani with:
Reshma Kewalramani United States
Thomas B. Neff United States
Hans Henrik Parving Denmark
Dov Wexler Israel
Hiroyasu Yamamoto Japan
Stanley E. Gräber United States
José Ramón González‐Porras Spain
Federica Delaini Italy
Raúl G. Carlini Venezuela
Ralph V. Boccia United States
Kai-Uwe Eckardt relative to Reshma Kewalramani United States Reshma Kewalramani's profile →
Citations per field
00.5×4.8×
Reshma Kewalramani · 1×
Citations per year

Countries citing papers authored by Kai-Uwe Eckardt

Since Specialization
Citations

This map shows the geographic impact of Kai-Uwe Eckardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai-Uwe Eckardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai-Uwe Eckardt more than expected).

Fields of papers citing papers by Kai-Uwe Eckardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai-Uwe Eckardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai-Uwe Eckardt. The network helps show where Kai-Uwe Eckardt may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kai-Uwe Eckardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kai-Uwe Eckardt Line = papers co-authored together Kai-Uwe Eckardt links everyone, so they are left out of the graph.

All Works

About Kai-Uwe Eckardt

Kai-Uwe Eckardt is a scholar working on Hematology, Genetics and Biochemistry, having authored 4 papers that have together received 2.3k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (3 papers), Blood transfusion and management (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Mesenchymal stem cell research (1 paper), Cancer, Hypoxia, and Metabolism (1 paper), High Altitude and Hypoxia (1 paper), Erythrocyte Function and Pathophysiology (1 paper) and Iron Metabolism and Disorders (1 paper). The work is most often cited by research in Nephrology (921 citations), Hematology (1.1k citations) and Genetics (456 citations). Kai-Uwe Eckardt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Scott D. Solomon, Janet B. McGill, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Robert D. Toto, Jan Feyzi, Hans Henrik Parving and Ajay Singh.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026